Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.

Also called NCT06717685

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 210 participants (planned count) (from the registry)
Sponsor
Rashid Latif Medical College (from the registry)
Registry
  • NCT NCT06717685
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06717685. Randomized; single masking; primary purpose treatment. Start 2024-10-28 (actual); primary completion 2025-01-27 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients
Condition
Supraventricular Tachycardia (SVtach)
Intervention (Drug)
Adenosine
Intervention (Drug)
Verapamil Injection
Lead sponsor
Rashid Latif Medical College (class: other)
Collaborator
Punjab Institute of Cardology (class: other)
Collaborator
Himmel Pharmaceutical private limited, Pakistan (class: not stated)

Record details

Record id
cardio:ct-nct06717685
Content hash
cf438be03beac23d0c445a655e3d9a9961a1c80e8793f84209071e9c81415f30